EP Patent

EP3955894A1 — Self-emulsifying drug delivery systems for delivery of lipophilic compounds

Assigned to Yissum Research Development Co of Hebrew University of Jerusalem · Expires 2022-02-23 · 4y expired

What this patent protects

The present disclosure provides self-emulsifying drug delivery systems for delivery of lipophilic compounds, compositions, kits and unit dosage forms thereof, as well as processes for their preparation.

USPTO Abstract

The present disclosure provides self-emulsifying drug delivery systems for delivery of lipophilic compounds, compositions, kits and unit dosage forms thereof, as well as processes for their preparation.

Drugs covered by this patent

Patent Metadata

Patent number
EP3955894A1
Jurisdiction
EP
Classification
—
Expires
2022-02-23
Drug substance claim
No
Drug product claim
No
Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.